Vaxart recently made a licensing deal, and two research firms issued upbeat assessments of the company, making me more upbeat on VXRT stock. The post New Developments Have Made Vaxart Stock So Much Mo

Watch Out for a Selloff in Vaxart Stock

12:02pm, Friday, 09'th Jul 2021
Vaxart needs a Covid-19 vaccine approved and selling on the market before the established mega-cap names take all the sales. The post Watch Out for a Selloff in Vaxart Stock appeared first on Investor
Vaxart (VXRT) enters a licensing agreement with Altesa Biosciences, Inc., whereby the latter gets rights to develop, manufacture and commercialize vapendavir.

Vaxart Stock Fell 3.8%: Why It Happened

04:31pm, Wednesday, 07'th Jul 2021
The stock price of Vaxart Inc (NASDAQ: VXRT) fell by 3.8%. This is why it happened.
Vaxart Inc (NASDAQ: VXRT) has granted Altesa Biosciences Inc an exclusive worldwide license to develop and commercialize Vaxart's patented formulation of the capsid-binding Vapendavir, a clinical
VXRT stock is known to be a fast mover. Any piece of good news could prove to be a multi-bagger for investors who take an early position.
VXRT stock just received a buy recommendation and a $13 price target from Jefferies, based on the promise of a oral vaccine instead of a needle. The post Will the Promise of Avoiding the Needle Pay Of
Today, VXRT stock is climbing higher on an otherwise red day for the markets, as many speculate retail investors could be behind this rise. The post VXRT Stock: Can Redditors Help Vaxart Power Higher?
Vaxart is still not worth today's price. VXRT stock is worth no more than $6, especially if it's going to need another capital raise.
Investors need to pay close attention to Vaxart (VXRT) stock based on the movements in the options market lately.
The declines appear to be caused simply by volatility that's common with small biotech stocks.

Is It Too Late to Buy Vaxart Stock?

09:56am, Tuesday, 15'th Jun 2021
The science looks fishy for this small-cap biotech.

VXRT Stock Price: 21.9% Increase Explanation

04:50pm, Saturday, 12'th Jun 2021
The stock price of Vaxart Inc (NASDAQ: VXRT) increased by 21.9% yesterday. This is why it happened.
Stock price plunged in February due to perceived weak antibody responses. Now the company has analogous data showing how immune responses in other areas can overcome the lack of antibody activity.
VXRT stock is on the move as the company received some very bullish coverage from an analyst initiating coverage today. The post VXRT Stock: Why Redditors Are Betting on a Big Squeeze With Vaxart Toda
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE